Jennison Associates LLC Pliant Therapeutics, Inc. Transaction History

Jennison Associates LLC

  • $160 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
SELL
$18.12 - $30.56 $21.3 Million - $36 Million
-1,176,588 Reduced 95.86%
50,824 $920,000
Q1 2023

Apr 26, 2023
SELL
$18.73 - $36.26 $9.48 Million - $18.4 Million
-506,178 Reduced 29.2%
1,227,412 $32.6 Million
Q4 2022

Feb 09, 2023
SELL
$17.0 - $25.43 $125,579 - $187,851
-7,387 Reduced 0.42%
1,733,590 $33.5 Million
Q3 2022

Nov 01, 2022
BUY
$7.67 - $24.23 $13.4 Million - $42.2 Million
1,740,977 New
1,740,977 $36.4 Million

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email